Nota de campo
Sesgos de confusión por indicación y gravedad en estudios observacionales
Confounding bias due to indication and severity in observational studies
Javier Nuevoa,
, Mónica Tafallaa, Luis Corderoa, Montserrat Ruizb, Eva Calvob, Javier Románc, Jesús Mayod
a Departamento Médico, AstraZeneca Farmacéutica Spain S.A., Madrid, España
b Departamento de Proyectos Sanitarios, Ibermutuamur M.A.T.E.P.S., Madrid, España
c Consejo Médico, Ibermutuamur M.A.T.E.P.S., Madrid, España
d Departamento Médico de Contingencias Profesionales, Ibermutuamur M.A.T.E.P.S., Madrid, España
Read
1990
Timeswas read the article
610
Total PDF
1380
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 19 | 10 | 29 |
| 2025 5 | 85 | 33 | 118 |
| 2025 4 | 94 | 34 | 128 |
| 2025 3 | 76 | 34 | 110 |
| 2025 2 | 80 | 20 | 100 |
| 2025 1 | 53 | 20 | 73 |
| 2024 12 | 58 | 24 | 82 |
| 2024 11 | 68 | 45 | 113 |
| 2024 10 | 65 | 31 | 96 |
| 2024 9 | 58 | 21 | 79 |
| 2024 8 | 94 | 29 | 123 |
| 2024 7 | 63 | 31 | 94 |
| 2024 6 | 37 | 20 | 57 |
| 2024 5 | 52 | 29 | 81 |
| 2024 4 | 48 | 11 | 59 |
| 2024 3 | 48 | 22 | 70 |
| 2024 2 | 49 | 39 | 88 |
| 2024 1 | 49 | 18 | 67 |
| 2023 12 | 34 | 8 | 42 |
| 2023 11 | 37 | 20 | 57 |
| 2023 10 | 38 | 23 | 61 |
| 2023 9 | 35 | 19 | 54 |
| 2023 8 | 27 | 15 | 42 |
| 2023 7 | 51 | 23 | 74 |
| 2023 6 | 40 | 17 | 57 |
| 2023 5 | 22 | 14 | 36 |
Show all
